Prometheus Biosciences, Inc. EBITDA Margin 2021-2023 | RXDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Prometheus Biosciences, Inc. (RXDX) over the last 10 years. The current EBITDA margin for Prometheus Biosciences, Inc. as of March 31, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-03-31 | $0.00B | $-0.17B | -4225.00% |
| 2022-12-31 | $0.01B | $-0.15B | -2114.29% |
| 2022-09-30 | $0.01B | $-0.14B | -1928.57% |
| 2022-06-30 | $0.01B | $-0.12B | -1757.14% |
| 2022-03-31 | $0.01B | $-0.11B | -1800.00% |
| 2021-12-31 | $0.00B | $-0.09B | -2933.33% |
| 2021-09-30 | $0.00B | $-0.07B | -3350.00% |
| 2021-06-30 | $0.00B | $-0.05B | -4700.00% |
| 2021-03-31 | $0.00B | $-0.04B | -3500.00% |
| 2020-12-31 | $0.00B | $-0.03B | inf% |
